Prospective study on the behaviour of the metalloprotease ADAMTS13 and of von Willebrand factor after bone marrow transplantation

British Journal of Haematology

Volumn 134, Issue 2, 2006, Pages 187-195

  Peyvandi, F ^a   Siboni, S M ^a   Lambertenghi Deliliers, D ^b   Lavoretano, S ^a   De Fazio, N ^b   Moroni, B ^a   Lambertenghi Deliliers, G ^b   Mannuccio Mannucci, P ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

Author keywords

ADAMTS13; Bone marrow transplantation; Thrombotic microangiopathies; Von Willebrand factor

Indexed keywords

VON WILLEBRAND FACTOR; VON WILLEBRAND FACTOR CLEAVING PROTEINASE;

ADULT; AGED; ARTICLE; BONE MARROW TRANSPLANTATION; CLINICAL ARTICLE; ENZYME ACTIVITY; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; THROMBOTIC THROMBOCYTOPENIC PURPURA;

ADAM PROTEINS; ADULT; AGED; BONE MARROW TRANSPLANTATION; FEMALE; GRAFT VS HOST DISEASE; HEMATOLOGIC NEOPLASMS; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PURPURA, THROMBOTIC THROMBOCYTOPENIC; TRANSPLANTATION CONDITIONING; VON WILLEBRAND FACTOR;

EID: 33745123633     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2006.06126.x     Document Type: Article

References (39)

1. Allford S.L. Bird J.M. Marks D.I. ( 2002) Thrombotic thrombocytopenic purpura following stem cell transplantation. Leukemia and Lymphoma, 43, 1921 1926.
2. Arai S. Allan C. Streiff M. Hutchins G.M. Vogelsang G.B. Tsai H.M. ( 2001) von Willebrand factor-cleaving protease activity and proteolysis of von Willebrand factor in bone marrow transplant-associated thrombotic microangiopathy. Hematology Journal, 2, 292 299.
3. Budde U. Drewke E. Mainusch K. Schneppenheim R. ( 2002) Laboratory diagnosis of congenital von Willebrand disease. Seminars in Thrombosis and Hemostasis, 28, 173 190.
4. Cahn J.Y. Klein J.P. Lee S.J. Milpied N. Blaise D. Antin J.H. Leblond V. Ifrah N. Jouet J.P. Loberiza F. Ringden O. Barrett A.J. Horowitz M.M. Socie G., Societe Francaise de Greffe de Moelle et Therapie Cellulaire, Dana Farber Cancer Institute, International Bone Marrow Transplant Registry. Related Articles, Links ( 2005) Prospective evaluation of 2 acute graft-versus-host (GVHD) grading systems: a joint Societe Francaise de Greffe de Moelle et Therapie Cellulaire (SFGM-TC), Dana Farber Cancer Institute (DFCI), and International Bone Marrow Transplant Registry (IBMTR) prospective study. Blood, 106, 1495 1500.
5. Charba D. Moake J.L. Harris M.A. Hester J.P. ( 1993) Abnormalities of von Willebrand factor multimers in drug associated thrombotic microangiopathies. American Journal of Hematology, 42, 268 277.
6. Corti P. Bonanomi S. Vallinoto C. Balduzzi A. Uderzo C. Cazzaniga G. Gaipa G. Dassi M. Perseghin P. Rovelli A. ( 2002) Defibrotide as a promising treatment for thrombotic thrombocytopenic purpura in patients undergoing bone marrow transplantation. Bone Marrow Transplantation, 29, 542 543.
7. Dong J.F. Moake J.L. Nolasco L. Bernardo A. Arceneaux W. Shrimpton C.N. Schade A.J. McIntire L.V. Fujikawa K. Lopez J.A. ( 2002) ADAMTS-13 rapidly cleaves newly secreted ultralarge von Willebrand factor multimers on the endothelial surface under flowing conditions. Blood, 100, 4033 4039.
8. Dong J.F. Moake J.L. Bernardo A. Fujikawa K. Ball C. Nolasco L. Lopez J.A. Cruz M.A. ( 2003) ADAMTS-13 metalloprotease interacts with the endothelial cell-derived ultra-large von Willebrand factor. Journal of Biological Chemistry, 278, 29633 29639.
9. Dong J.F. Whitelock J. Bernardo A. Ball C. Cruz M.A. ( 2004) Variations among normal individuals in the cleavage of endothelial-derived ultra-large von Willebrand factor under flow. Journal of Thrombosis and Hemostasis, 2, 1460 1466.
10. Elliott M.A. Nichols W.L. ( 2001) Thrombotic thrombocytopenic purpura and hemolytic uremic syndrome. Mayo Clinic Proceedings, 76, 1154 1162.
11. Fassas A.B. Buddharaju L.N. Rapoport A. Cottler-Fox M. Drachenberg C. Meisenberg B. Tricot G. ( 2001) Fatal disseminated adenoviral infection associated with thrombotic thrombocytopenic purpura after allogeneic bone marrow transplantation. Leukemia and Lymphoma, 42, 801 804.
12. Fuge R. Bird J.M. Fraser A. Hart D. Hunt L. Cornish J.M. Goulden N. Oakhill A. Pamphilon D.H. Steward C.G. Marks D.I. ( 2001) The clinical features, risk factors and outcome of thrombotic thrombocytopenic purpura occurring after bone marrow transplantation. British Journal of Haematology, 113, 58 64.
13. Furlan M. Robles R. Lammle B. ( 1996) Partial purification and characterization of a protease from human plasma cleaving von Willebrand factor to fragments produced by in vivo proteolysis. Blood, 87, 4223 4234.
14. Furlan M. Robles R. Solenthaler M. Wassmer M. Sandoz P. Lammle B. ( 1997) Deficient activity of von Willebrand factor-cleaving protease in chronic relapsing thrombotic thrombocytopenic purpura. Blood, 89, 3097 3103.
15. Furlan M. Robles R. Galbusera M. Remuzzi G. Kyrle P.A. Brenner B. Krause M. Scharrer I. Aumann V. Mittler U. Solenthaler M. Lammle B. ( 1998) von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome. New England Journal of Medicine, 339, 1578 1584.
16. George J.N. Vesely S.K. ( 2003) Thrombotic thrombocytopenic purpura: from the bench to the bedside, but not yet to the community. Annals of Internal Medicine, 138, 152 153.
17. George J.N. Li X. McMinn J.R. Terrell D.R. Vesely S.K. Selby G.B. ( 2004) Thrombotic thrombocytopenic purpura-hemolytic uremic syndrome following allogeneic HPC transplantation: a diagnostic dilemma. Transfusion, 44, 294 304.
18. Gerritsen H.E. Turecek P.L. Schwarz H.P. Lammle B. Furlan M. ( 1999) Assay of von Willebrand factor (vWF)-cleaving protease based on decreased collagen binding affinity of degraded vWF: a tool for the diagnosis of thrombotic thrombocytopenic purpura (TTP). Thrombosis and Haemostasis, 82, 1386 1389.
19. Guinan E.C. Tarbell N.J. Niemeyer C.M. Sallan S.E. Weinstein H.J. ( 1988) Intravascular hemolysis and renal insufficiency after bone marrow transplantation. Blood, 72, 451 455.
20. Hings I.M. Severson R. Filipovich A.H. Blazar B.R. Kersey J.H. Ramsay N.K. McGlave P.B. Weisdorf D.J. ( 1994) Treatment of moderate and severe acute GVHD after allogeneic bone marrow transplantation. Transplantation, 58, 437 442.
21. Holler E. Kolb H.J. Hiller E. Mraz W. Lehmacher W. Gleixner B. Seeber C. Jehn U. Gerhartz H.H. Brehm G. ( 1989) Microangiopathy in patients on cyclosporine prophylaxis who developed acute graft-versus-host disease after HLA-identical bone marrow transplantation. Blood, 73, 2018 2024.
22. Holler E. Kolb H.J. Moller A. Kempeni J. Liesenfeld S. Pechumer H. Lehmacher W. Ruckdeschel G. Gleixner B. Riedner C. ( 1990) Increased serum levels of tumor necrosis factor alpha precede major complications of bone marrow transplantation. Blood, 75, 1011 1016.
23. Iacopino P. Pucci G. Arcese W. Bosi A. Falda M. Locatelli F. Marenco P. Miniero R. Morabito F. Rossetti F. Sica S. Uderzo C. Bacigalupo A. ( 1999) Severe thrombotic microangiopathy: an infrequent complication of bone marrow transplantation. Gruppo Italiano Trapianto Midollo Osseo (GITMO). Bone Marrow Transplantation, 24, 47 51.
24. Krenger W. Hill G.R. Ferrara J.L. ( 1997) Cytokine cascades in acute graft-versus-host disease. Transplantation, 64, 553 558.
25. Levy G.G. Nichols W.C. Lian E.C. Foroud T. McClintick J.N. McGee B.M. Yang A.Y. Siemieniak D.R. Stark K.R. Gruppo R. Sarode R. Shurin S.B. Chandrasekaran V. Stabler S.P. Sabio H. Bouhassira E.E. Upshaw J.D. Jr. Ginsburg D. Tsai H.M. ( 2001) Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura. Nature, 413, 488 494.
26. Licciardello J.T.W. Moake J.L. Rudy C.K. Karp D.D. Homg W.K. ( 1985) Elevated plasma von Willebrand factor levels and arterial occlusive complications associated with cisplatin-based chemotherapy. Oncology, 42, 296 300.
27. Mannucci P.M. Canciani M.T. Forza I. Lussana F. Lattuada A. Rossi E. ( 2001) Changes in health and disease of the metalloprotease that cleaves von Willebrand factor. Blood, 98, 2730 2735.
28. Padilla A. Moake J.L. Bernardo A. Ball C. Wang Y. Arya M. Nolasco L. Turner N. Berndt M.C. Anvari B. Lopez J.A. Dong J.F. ( 2004) P-selectin anchors newly released ultralarge von Willebrand factor multimers to the endothelial cell surface. Blood, 103, 2150 2156.
29. Pettitt A.R. Clark R.E. ( 1994) Thrombotic microangiopathy following bone marrow transplantation. Bone Marrow Transplantation, 14, 495 504.
30. Peyvandi F. Ferrari S. Lavoretano S. Canciani M.T. Mannucci P.M. ( 2004) von Willebrand factor cleaving protease (ADAMTS-13) and ADAMTS-13 neutralizing autoantibodies in 100 patients with thrombotic thrombocytopenic purpura. British Journal of Haematology, 127, 433 439.
31. van der Plas R.M. Schiphorst M.E. Huizinga E.G. Hene R.J. Verdonck L.F. Sixma J.J. Fijnheer R. ( 1999) von Willebrand factor proteolysis is deficient in classic, but not in bone marrow transplantation-associated, thrombotic thrombocytopenic purpura. Blood, 93, 3798 3802.
32. Przepiorka D. Weisdorf D. Martin P. Klingemann H.G. Beatty P. Hows J. Thomas E.D. ( 1995) 1994 Consensus Conference on Acute GVHD Grading. Bone Marrow Transplantation, 15, 825 828.
33. Ruggeri Z.M. Zimmerman T.S. ( 1981) The complex multimeric composition of factor VIII/von Willebrand factor. Blood, 57, 1140 1143.
34. Ruutu T. Hermans J. Niederwieser D. Gratwohl A. Kiehl M. Volin L. Bertz H. Ljungman P. Spence D. Verdonck L.F. Prentice H.G. Bosi A. Du Toit C.E. Brinch L. Apperley J.F., EBMT Chronic Leukaemia Working Party ( 2002) Thrombotic thrombocytopenic purpura after allogeneic stem cell transplantation: a survey of the European Group for Blood and Marrow Transplantation (EBMT). British Journal of Haematology, 118, 1112 1119.
35. Sarkodee-Adoo C. Sotirescu D. Sensenbrenner L. Rapoport A.P. Cottler-Fox M. Tricot G. Ruehle K. Meisenberg B. ( 2003) Thrombotic microangiopathy in blood and marrow transplant patients receiving tacrolimus or cyclosporine A. Transfusion, 43, 78 84.
36. Teruya J. Styler M. Verde S. Topolsky D. Crilley P. ( 2001) Questionable efficacy of plasma exchange for thrombotic thrombocytopenic purpura after bone marrow transplantation. Journal of Clinical Apheresis, 16, 169 174.
37. Tsai H.M. ( 1996) Physiologic cleavage of von Willebrand factor by a plasma protease is dependent on its conformation and requires calcium ion. Blood, 87, 4235 4244.
38. Tsai H.M. Lian E.C. ( 1998) Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura. New England Journal of Medicine, 339, 1585 1594.
39. Vesely S.K. George J.N. Lammle B. Studt J.D. Alberio L. El Harake M.A. Raskob G.E. ( 2003) ADAMTS13 activity in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: relation to presenting features and clinical outcomes in a prospective cohort of 142 patients. Blood, 102, 60 68.